ModelEdge

Telomir Pharmaceuticals Inc.
0001971532
Filing TypeS-3
Filing Date2/13/2025
Updated2/14/25, 3:01 PM

Filing

S-3
Earnings Release

Exhibits

S-3Registration Statement for Securities Offered under a Shelf Registration
EX-2.1
EX-5.1
EX-23.1
EX-23.2
EX-FILING FEESCALCULATION OF FILING FEE TABLES